Chou S, Erice A, Jordan M C, Vercellotti G M, Michels K R, Talarico C L, Stanat S C, Biron K K
Medical Service, VA Medical Center, Portland, OR 97201.
J Infect Dis. 1995 Mar;171(3):576-83. doi: 10.1093/infdis/171.3.576.
The UL97 phosphotransferase coding sequences of clinical cytomegalovirus (CMV) isolates, 10 resistant and 11 sensitive to ganciclovir, were compared to define mutations associated with drug resistance. In each ganciclovir-resistant isolate, a mutation was found that resulted in an amino acid substitution at codon 460 (4 isolates), codon 594 (2 isolates), or codon 595 (4 isolates). No sensitive isolate carried any of these mutations. Marker transfer studies showed that each mutation was capable of conferring ganciclovir resistance to the laboratory CMV strain AD169. Rapid diagnostic tests based on DNA amplification and restriction enzyme analysis were developed for these mutations. Specific mutant DNAs were detected when they constituted at least 10% of the population in the specimen. Several mutations in UL97 appear to be common markers for ganciclovir resistance, and their detection may be a rapid alternative to conventional cell culture susceptibility testing.
对10株对更昔洛韦耐药和11株对更昔洛韦敏感的临床巨细胞病毒(CMV)分离株的UL97磷酸转移酶编码序列进行比较,以确定与耐药相关的突变。在每株对更昔洛韦耐药的分离株中,均发现一个突变,该突变导致460密码子(4株分离株)、594密码子(2株分离株)或595密码子(4株分离株)发生氨基酸取代。没有敏感分离株携带这些突变中的任何一种。标记转移研究表明,每个突变都能够赋予实验室CMV毒株AD169对更昔洛韦的耐药性。针对这些突变开发了基于DNA扩增和限制酶分析的快速诊断试验。当标本中的特定突变DNA至少占群体的10%时,即可检测到。UL97中的几种突变似乎是更昔洛韦耐药的常见标志物,检测这些突变可能是传统细胞培养药敏试验的一种快速替代方法。